- Home
- RFM vs EDAP Comparison
RFM vs EDAP Comparison
Compare RFM & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RFM | EDAP |
|---|---|---|
| Founded | 2020 | 1979 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.9M | 137.6M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | RFM | EDAP |
|---|---|---|
| Price | $14.23 | $3.78 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 20.7K | ★ 73.2K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 9.74% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $74,853,925.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.67 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.61 |
| 52 Week Low | $12.89 | $1.21 |
| 52 Week High | $16.41 | $4.24 |
Technical Indicators
Market Signals| Indicator | RFM | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | 55.64 | 58.63 |
| Support Level | $14.08 | $3.44 |
| Resistance Level | $14.23 | $4.24 |
| Average True Range (ATR) | 0.10 | 0.35 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 74.83 | 50.22 |
Price Performance
Historical ComparisonAbout RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.